Remicalm, LLC, a medical diagnostic and imaging device company, engages in the design, manufacture, and marketing of cancer diagnostic, screening, imaging, and monitoring devices in the United States. The company, through its subsidiaries, provides medical devices for the imaging and diagnosis of oral, cervical, skin, bladder, esophagus, and colon cancers. Its products are used for the early detection and treatment of cancers and pre-cancers that exist in the cells that line the internal and external surfaces of the body. Remicalm, LLC, was incorporated in 2006 and is based in Houston, Texas.